Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | |
| Sales | 23,740 |
| Gross Profit | 23,740 |
| Operating Expenses | 37,755 |
| Operating Income | -14,015 |
| Other Income | 549 |
| Pre-tax Income | -13,466 |
| Income Tax | -5 |
| Net Income Continuous | -13,461 |
| Net Income | $-13,461 |
| EPS Basic Total Ops | -12.22 |
| EPS Basic Continuous Ops | -12.22 |
| EPS Diluted Total Ops | -12.22 |
| EPS Diluted Continuous Ops | -12.22 |
| EBITDA(a) | $-12,231 |